Skip to Main Content

Paper Details

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Eur Urol
135
2019
BRCA, BRCA1, BRCA1 mutation, BRCA1/2, BRCA1/2 mutation, BRCA1/2 mutations, BRCA2, BRCA2 Mutation, BRCA2 mutation, BRCA2 mutations, Cancer, Men, PATIENT, PSA, Participants, PrCa, Prostate-specific Antigen, cancer, kallikrein, men, patients, person, prostate cancer, prostate cancers, prostate-specific antigen, prostate-specific-antigen, tumour, tumours
Author NameAffiliation
Elizabeth BancroftInstitute of Cancer Research, Royal Marsden NHS Foundation Trust
Sarah ThomasRoyal Marsden NHS Foundation Trust
Christi J van AsperenLeiden University Medical Center
Lambertus A KiemeneyRadboud University Medical Center
Cezary CybulskiInternational Hereditary Cancer Center, Pomeranian Medical University in Szczecin
Susan M DomchekBasser Research Center, University of Pennsylvania
Louise IzattClinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust
William D FoulkesResearch Institute of McGill University Health Centre, Canada Lady Davis Institute, Jewish General Hospital, McGill University
William D FoulkesResearch Institute of McGill University Health Centre, Canada Lady Davis Institute, Jewish General Hospital, McGill University
Armen AprikianResearch Institute of McGill University Health Centre
Declan G MurphyUniversity of Melbourne, Peter MacCallum Cancer Centre
Judy KirkCrown Princess Mary Cancer Centre, Westmead Hospital, Australia Sydney Medical School, University of Sydney, The Westmead Institute for Medical Research
Nicholas PachterKing Edward Memorial Hospital, University of Western Australia
Teresa Ram??n y CajalHospital de Sant Pau
Christopher S Foster
Henrik Gr??nbergUniversity Hospital
Henrik Gr??nbergUniversity Hospital
Freddie C HamdyChurchill Hospital, University of Oxford
Vincent KhooRoyal Marsden NHS Foundation Trust, UK St George's Hospital, The Institute of Cancer Research, The University of Melbourne
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University in Szczecin
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University in Szczecin
Tim DudderidgeUniversity Hospital Southampton
Zsofia Kote-JaraiInstitute of Cancer Research
Rosalind A EelesInstitute of Cancer Research, Royal Marsden NHS Foundation Trust
  • 1 - 24

Datasets